inovmedИнновационная медицина КубаниInnovative Medicine of Kuban2541-9897Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 110.35401/2541-9897-2025-10-1-136-143inovmed-1076Research ArticleОБЗОРЫREVIEWSСтимуляция блуждающего нерва как метод лечения хронической сердечной недостаточностиVagus Nerve Stimulation for Treatment of Chronic Heart Failurehttps://orcid.org/0009-0003-0159-9182КарибоваМ. В.KaribovaMariya V.

Карибова Мария Васильевна, врач-кардиолог; аспирант кафедры терапии № 1 ФПК и ППС

350086, Краснодар, ул. 1 мая, 167

Mariya V. Karibova, Cardiologist; Postgraduate Student, Therapy Department No. 1, Faculty of Continuing Professional Development and Retraining

ulitsa 1 Maya 167, Krasnodar, 350086

mari.karibova96@mail.ruhttps://orcid.org/0000-0002-7538-0437КручиноваС. В.KruchinovaSofiya V.

Кручинова София Владимировна, к. м. н., врач-кардиолог; ассистент кафедры терапии № 1 ФПК и ППС

350086, Краснодар, ул. 1 мая, 167

Sofiya V. Kruchinova, Cand. Sci. (Med.), Cardiologist; Assistant Professor at the Therapy Department No. 1, Faculty of Continuing Professional Development and Retraining

ulitsa 1 Maya 167, Krasnodar, 350086

https://orcid.org/0000-0002-8931-0376ШварцВ. А.ShvartzVladimir A.

Шварц Владимир Александрович, д. м. н., врач-кардиолог, ведущий научный сотрудник отделения хирургического лечения интерактивной патологии, профессор кафедры сердечно-сосудистой хирургии с курсом аритмологии и клинической  электрофизиологии

Москва

Vladimir A. Shvartz, Dr. Sci. (Med.), Cardiologist, Leading Researcher, Department of Surgical Treatment for Interactive Pathology, Professor at the Department of Cardiovascular Surgery with the Course of Arrhythmology and Clinical Electrophysiology

Moscow

https://orcid.org/0009-0009-7063-3798ГендуговаМ. Н.GendugovaMilana N.

Гендугова Милана Нургалиевна, врач-кардиолог; аспирант кафедры терапии № 1 ФПК и ППС

350086, Краснодар, ул. 1 мая, 167

Milana N. Gendugova, Cardiologist; Postgraduate Student, Therapy Department No. 1, Faculty of Continuing Professional Development and Retraining

ulitsa 1 Maya 167, Krasnodar, 350086

https://orcid.org/0000-0001-8600-0199КосмачеваЕ. Д.KosmachevaElena D.

Космачева Елена Дмитриевна, д. м. н., заместитель главного врача по лечебной работе; заведующая кафедрой терапии №1 ФПК и ППС

350086, Краснодар, ул. 1 мая, 167

Elena D. Kosmacheva, Dr. Sci. (Med.), Deputy Chief Physician for Medical Work; Head of the Therapy Department No. 1, Faculty of Continuing Professional Development and Retraining

ulitsa 1 Maya 167, Krasnodar, 350086

Кубанский государственный медицинский университет; Научно-исследовательский институт – Краевая клиническая больница № 1 им. проф. С.В. ОчаповскогоРоссияKuban State Medical University; Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1Russian FederationНациональный медицинский исследовательский центр сердечно-сосудистой хирургии им. А.Н. БакулеваРоссияBakulev National Medical Research Center for Cardiovascular SurgeryRussian Federation202530032025101136143Copyright © Карибова М.В., Кручинова С.В., Шварц В.А., Гендугова М.Н., Космачева Е.Д., 20252025Карибова М.В., Кручинова С.В., Шварц В.А., Гендугова М.Н., Космачева Е.Д.Karibova M.V., Kruchinova S.V., Shvartz V.A., Gendugova M.N., Kosmacheva E.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.innovmedkub.ru/jour/article/view/1076Актуальность

Актуальность: Сердечная недостаточность является исходом большинства болезней сердечно-сосудистой системы. Распространенность данного патологического синдрома продолжает увеличиваться ежегодно, что подчеркивает важность разработки терапевтических стратегий для предупреждения неблагоприятных исходов. В статье приведен обзор современных данных о влиянии стимуляции блуждающего нерва на течение хронической сердечной недостаточности.

Цель исследования

Цель исследования: Обобщение имеющихся литературных данных о влиянии стимуляции блуждающего нерва на течение хронической сердечной недостаточности.

Материалы и методы

Материалы и методы: Проведен поиск актуальной информации по исследуемой теме за последние 20 лет в электронных базах данных PubMed, eLIBRARY, по ключевым словам: блуждающий нерв, сердечная недостаточность, стимуляция, фракция выброса. Поиск проводили по заголовкам, содержанию аннотаций, ключевым словам.

Результаты

Результаты: В результате проведенного обзора было выявлено, что стимуляция блуждающего нерва оказывает благоприятные эффекты в отношении сердечной недостаточности и требует дальнейшего тщательного исследования данной методики.

Background

Background: Heart failure is the outcome of most cardiovascular diseases. Its prevalence continues to increase annually, which emphasizes the importance of developing therapeutic strategies to prevent adverse outcomes. This article reviews current data on the effect of vagus nerve stimulation on the course of chronic heart failure.

Objective

Objective: To summarize available literature data on the effect of vagus nerve stimulation on the course of chronic heart failure.

Materials and methods

Materials and methods: We searched PubMed and eLIBRARY for the relevant information over the last 20 years using the following keywords: vagus nerve, heart failure, stimulation, ejection fraction. The search was performed by titles, abstracts, and keywords.

Results

Results: This review revealed that vagus nerve stimulation has favorable effects in patients with heart failure and warrants further careful investigation.

блуждающий нервсердечная недостаточностьстимуляцияфракция выбросаvagus nerveheart failurestimulationejection fractionReferencesТепляков А.Т., Дибиров М.М., Болотская Л.А. и др. Модулирующее влияние карведилола на активацию цитокинов и регресс сердечной недостаточности у больных с постинфарктной дисфункцией сердца. Кардиология. 2004;44(9):50– 57. PMID: 15477776.Tepliakov AT, Dibirov MM, Bolotskaia LA, et al. Effect of carvedilol on blood levels of cytokines and symptoms of heart failure in patients with postinfarction cardiac dysfunction. Kardiologiia. 2004;44(9):50–57. (In Russ.). PMID: 15477776.Фролова Э.Б., Яушев М.Ф. Современное представление о хронической сердечной недостаточности. Вестник современной клинической медицины. 2013;6(2):87–93. https://doi.org/10.20969/vskm.2013.6(2).87-93Frolova EB, Yaushev MF. Current understanding of chronic heart failure. The Bulletin of Contemporary Clinical Medicine. 2013;6(2):87– 93. (In Russ.). https://doi.org/10.20969/vskm.2013.6(2).87-93Алиева А.М., Байкова И.Е., Воронкова К.В. и др. Гаммаглутамилтранспептидаза – перспективный биологический маркер сердечной недостаточности. Клиницист. 2022;16(1):12–20.Alieva AM, Baykova IE, Voronkova KV, et al. Gamma-glutamyl transpeptidase is a promising biological marker of heart failure. The Clinician. 2022;16(1):12–20. (In Russ.).Smith WM. Epidemiology of congestive heart failure. Am J Cardiol. 1985;55(2):3A–8A. PMID: 3966408. https://doi.org/10.1016/0002-9149(85)90789-1Smith WM. Epidemiology of congestive heart failure. Am J Cardiol. 1985;55(2):3A–8A. PMID: 3966408. https://doi.org/10.1016/0002-9149(85)90789-1Поляков Д.С., Фомин И.В., Беленков Ю.Н. и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА–ХСН. Кардиология. 2021;61(4):4–14. PMID: 33998403. https://doi.org/10.18087/cardio.2021.4.n1628Polyakov DS, Fomin IV, Belenkov YN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4–14. (In Russ.). PMID: 33998403. https://doi.org/10.18087/cardio.2021.4.n1628Benditt DG, Iskos D, Sakaguchi S. Chapter 3 - Autonomic nervous system and cardiac arrhythmias. In: Saksena S, Camm AJ, Boyden PA, Dorian P, Goldschlager N, eds. Electrophysiological Disorders of the Heart. Churchill Livingstone; 2005:49–67. https://doi.org/10.1016/B978-0-443-06570-5.50009-5Benditt DG, Iskos D, Sakaguchi S. Chapter 3 - Autonomic nervous system and cardiac arrhythmias. In: Saksena S, Camm AJ, Boyden PA, Dorian P, Goldschlager N, eds. Electrophysiological Disorders of the Heart. Churchill Livingstone; 2005:49–67. https://doi.org/10.1016/B978-0-443-06570-5.50009-5Синельников Р.Д., Синельников Я.Р. Атлас анатомии человека. Т. 4. Медицина; 1996:133–139.Sinelnikov RD, Sinelnikov YaR. Atlas of Human Anatomy. Vol. 4. Meditsina; 1996:133–139. (In Russ.).Schwartz PJ, La Rovere MT, De Ferrari GM, Mann DL. Autonomic modulation for the management of patients with chronic heart failure. Circ Heart Fail. 2015;8(3):619–628. PMID: 25991804. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001964Schwartz PJ, La Rovere MT, De Ferrari GM, Mann DL. Autonomic modulation for the management of patients with chronic heart failure. Circ Heart Fail. 2015;8(3):619–628. PMID: 25991804. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001964Dusi V, De Ferrari GM. Vagal stimulation in heart failure. Herz. 2021;46(6):541–549. PMID: 34716778. PMCID: PMC8642334. https://doi.org/10.1007/s00059-021-05076-5Dusi V, De Ferrari GM. Vagal stimulation in heart failure. Herz. 2021;46(6):541–549. PMID: 34716778. PMCID: PMC8642334. https://doi.org/10.1007/s00059-021-05076-5Desai MY, Watanabe MA, Laddu AA, Hauptman PJ. Pharmacologic modulation of parasympathetic activity in heart failure. Heart Fail Rev. 2011;16(2):179–193. PMID: 20924667. https://doi.org/10.1007/s10741-010-9195-1Desai MY, Watanabe MA, Laddu AA, Hauptman PJ. Pharmacologic modulation of parasympathetic activity in heart failure. Heart Fail Rev. 2011;16(2):179–193. PMID: 20924667. https://doi.org/10.1007/s10741-010-9195-1Сыровнев В.А., Лебедев Д.С., Михайлов Е.Н. Стимуляция блуждающего нерва в кардиологии. Трансляционная медицина. 2017;4(2):6–16. https://doi.org/10.18705/2311-4495-2017-4-2-6-16Syrovnev VA, Lebedev DS, Mikhaylov EN. Vagus nerve stimulation in cardiology. Translational Medicine. 2017;4(2):6–16. (In Russ.). https://doi.org/10.18705/2311-4495-2017-4-2-6-16Asconapé JJ, Moore DD, Zipes DP, Hartman LM, Duffell WH Jr. Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intraoperative device testing. Epilepsia. 1999;40(10):1452–1454. PMID: 10528943. https://doi.org/10.1111/j.1528-1157.1999.tb02019.xAsconapé JJ, Moore DD, Zipes DP, Hartman LM, Duffell WH Jr. Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intraoperative device testing. Epilepsia. 1999;40(10):1452–1454. PMID: 10528943. https://doi.org/10.1111/j.1528-1157.1999.tb02019.xVentureyra EC. Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept. Childs Nerv Syst. 2000;16(2):101–102. PMID: 10663816. https://doi.org/10.1007/s003810050021Ventureyra EC. Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept. Childs Nerv Syst. 2000;16(2):101–102. PMID: 10663816. https://doi.org/10.1007/s003810050021Peuker ET, Filler TJ. The nerve supply of the human auricle. Clin Anat. 2002;15(1):35–37. PMID: 11835542. https://doi.org/10.1002/ca.1089Peuker ET, Filler TJ. The nerve supply of the human auricle. Clin Anat. 2002;15(1):35–37. PMID: 11835542. https://doi.org/10.1002/ca.1089Chen M, Yu L, Ouyang F, et al. The right side or left side of noninvasive transcutaneous vagus nerve stimulation: based on conventional wisdom or scientific evidence?. Int J Cardiol. 2015;187:44–45. PMID: 25828310. https://doi.org/10.1016/j.ijcard.2015.03.351Chen M, Yu L, Ouyang F, et al. The right side or left side of noninvasive transcutaneous vagus nerve stimulation: based on conventional wisdom or scientific evidence?. Int J Cardiol. 2015;187:44–45. PMID: 25828310. https://doi.org/10.1016/j.ijcard.2015.03.351Butt MF, Albusoda A, Farmer AD, Aziz Q. The anatomical basis for transcutaneous auricular vagus nerve stimulation. J Anat. 2020;236(4):588–611. PMID: 31742681. PMCID: PMC7083568. https://doi.org/10.1111/joa.13122Butt MF, Albusoda A, Farmer AD, Aziz Q. The anatomical basis for transcutaneous auricular vagus nerve stimulation. J Anat. 2020;236(4):588–611. PMID: 31742681. PMCID: PMC7083568. https://doi.org/10.1111/joa.13122Ben-Menachem E, Revesz D, Simon BJ, Silberstein S. Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. Eur J Neurol. 2015;22(9):1260–1268. PMID: 25614179. PMCID: PMC5024045. https://doi.org/10.1111/ene.12629Ben-Menachem E, Revesz D, Simon BJ, Silberstein S. Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. Eur J Neurol. 2015;22(9):1260–1268. PMID: 25614179. PMCID: PMC5024045. https://doi.org/10.1111/ene.12629Nicholson WC, Kempf MC, Moneyham L, Vance DE. The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature. Neuropsychiatr Dis Treat. 2017;13:1677–1689. PMID: 28721049. PMCID: PMC5499939. https://doi.org/10.2147/NDT.S136065Nicholson WC, Kempf MC, Moneyham L, Vance DE. The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature. Neuropsychiatr Dis Treat. 2017;13:1677–1689. PMID: 28721049. PMCID: PMC5499939. https://doi.org/10.2147/NDT.S136065Verma N, Mudge JD, Kasole M, et al. Auricular vagus neuromodulation-a systematic review on quality of evidence and clinical effects. Front Neurosci. 2021;15:664740. PMID: 33994937. PMCID: PMC8120162. https://doi.org/10.3389/fnins.2021.664740Verma N, Mudge JD, Kasole M, et al. Auricular vagus neuromodulation-a systematic review on quality of evidence and clinical effects. Front Neurosci. 2021;15:664740. PMID: 33994937. PMCID: PMC8120162. https://doi.org/10.3389/fnins.2021.664740Stavrakis S, Elkholey K, Morris L, Niewiadomska M, Asad ZUA, Humphrey MB. Neuromodulation of inflammation to treat heart failure with preserved ejection fraction: a pilot randomized clinical trial. J Am Heart Assoc. 2022;11(3):e023582. PMID: 35023349. PMCID: PMC9238491. https://doi.org/10.1161/JAHA.121.023582Stavrakis S, Elkholey K, Morris L, Niewiadomska M, Asad ZUA, Humphrey MB. Neuromodulation of inflammation to treat heart failure with preserved ejection fraction: a pilot randomized clinical trial. J Am Heart Assoc. 2022;11(3):e023582. PMID: 35023349. PMCID: PMC9238491. https://doi.org/10.1161/JAHA.121.023582Zhou L, Filiberti A, Humphrey MB, et al. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction. Exp Physiol. 2019;104(1):28–38. PMID: 30398289. PMCID: PMC6312463. https://doi.org/10.1113/EP087351Zhou L, Filiberti A, Humphrey MB, et al. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction. Exp Physiol. 2019;104(1):28–38. PMID: 30398289. PMCID: PMC6312463. https://doi.org/10.1113/EP087351Konstam MA, Mann DL, Udelson JJE, et al. Advances in our clinical understanding of autonomic regulation therapy using vagal nerve stimulation in patients living with heart failure. Front Physiol. 2022;13:857538. PMID: 35530511. PMCID: PMC9068946. https://doi.org/10.3389/fphys.2022.857538Konstam MA, Mann DL, Udelson JJE, et al. Advances in our clinical understanding of autonomic regulation therapy using vagal nerve stimulation in patients living with heart failure. Front Physiol. 2022;13:857538. PMID: 35530511. PMCID: PMC9068946. https://doi.org/10.3389/fphys.2022.857538Einbrodt. Über Herzreizung und ihr Verhältniss zum Blutdruck. Sitzungsberichte der Akademie der Wissenschaften mathematisch-naturwissenschaftliche Klasse. 1860;38:345–359. (In German).Einbrodt. Über Herzreizung und ihr Verhältniss zum Blutdruck. Sitzungsberichte der Akademie der Wissenschaften mathematisch-naturwissenschaftliche Klasse. 1860;38:345–359. (In German).Yoon MS, Han J, Tse WW, Rogers R. Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles. Am Heart J. 1977;93(1):60–65. PMID: 831412. https://doi.org/10.1016/s0002-8703(77)80172-5Yoon MS, Han J, Tse WW, Rogers R. Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles. Am Heart J. 1977;93(1):60–65. PMID: 831412. https://doi.org/10.1016/s0002-8703(77)80172-5Kolman BS, Verrier RL, Lown B. The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions. Circulation. 1975;52(4):578–585. PMID: 239801. https://doi.org/10.1161/01.cir.52.4.578Kolman BS, Verrier RL, Lown B. The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions. Circulation. 1975;52(4):578–585. PMID: 239801. https://doi.org/10.1161/01.cir.52.4.578Kent KM, Smith ER, Redwood DR, Epstein SE. Electrical stability of acutely ischemic myocardium. Influences of heart rate and vagal stimulation. Circulation. 1973;47(2):291–298. PMID: 4684930. https://doi.org/10.1161/01.cir.47.2.291Kent KM, Smith ER, Redwood DR, Epstein SE. Electrical stability of acutely ischemic myocardium. Influences of heart rate and vagal stimulation. Circulation. 1973;47(2):291–298. PMID: 4684930. https://doi.org/10.1161/01.cir.47.2.291Myers RW, Pearlman AS, Hyman RM, et al. Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation. 1974;49(5):943–947. PMID: 4828616. https://doi.org/10.1161/01.cir.49.5.943Myers RW, Pearlman AS, Hyman RM, et al. Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation. 1974;49(5):943–947. PMID: 4828616. https://doi.org/10.1161/01.cir.49.5.943Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68(5):1471–1781. PMID: 2019002. https://doi.org/10.1161/01.res.68.5.1471Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68(5):1471–1781. PMID: 2019002. https://doi.org/10.1161/01.res.68.5.1471Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation. 2004;109(1):120–124. PMID: 14662714. https://doi.org/10.1161/01.CIR.0000105721.71640.DALi M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation. 2004;109(1):120–124. PMID: 14662714. https://doi.org/10.1161/01.CIR.0000105721.71640.DAZhang Y, Popovic ZB, Bibevski S, et al. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail. 2009;2(6):692–699. PMID: 19919995. https://doi.org/10.1161/CIRCHEARTFAILURE.109.873968Zhang Y, Popovic ZB, Bibevski S, et al. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail. 2009;2(6):692–699. PMID: 19919995. https://doi.org/10.1161/CIRCHEARTFAILURE.109.873968Sabbah HN, Ilsar I, Zaretsky A, Rastogi S, Wang M, Gupta RC. Vagus nerve stimulation in experimental heart failure. Heart Fail Rev. 2011;16(2):171–178. PMID: 21128115. PMCID: PMC3784341. https://doi.org/10.1007/s10741-010-9209-zSabbah HN, Ilsar I, Zaretsky A, Rastogi S, Wang M, Gupta RC. Vagus nerve stimulation in experimental heart failure. Heart Fail Rev. 2011;16(2):171–178. PMID: 21128115. PMCID: PMC3784341. https://doi.org/10.1007/s10741-010-9209-zWu Z, Liao J, Liu Q, Zhou S, Chen M. Chronic vagus nerve stimulation in patients with heart failure: challenge or failed translation?. Front Cardiovasc Med. 2023;10:1052471. PMID: 37534273. PMCID: PMC10390725. https://doi.org/10.3389/fcvm.2023.1052471Wu Z, Liao J, Liu Q, Zhou S, Chen M. Chronic vagus nerve stimulation in patients with heart failure: challenge or failed translation?. Front Cardiovasc Med. 2023;10:1052471. PMID: 37534273. PMCID: PMC10390725. https://doi.org/10.3389/fcvm.2023.1052471Hamann JJ, Ruble SB, Stolen C, et al. Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure. Eur J Heart Fail. 2013;15(12):1319–1326. PMID: 23883651. PMCID: PMC3895958. https://doi.org/10.1093/eurjhf/hft118Hamann JJ, Ruble SB, Stolen C, et al. Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure. Eur J Heart Fail. 2013;15(12):1319–1326. PMID: 23883651. PMCID: PMC3895958. https://doi.org/10.1093/eurjhf/hft118Li M, Zheng C, Kawada T, Inagaki M, Uemura K, Sugimachi M. Chronic vagal nerve stimulation exerts additional beneficial effects on the beta-blocker-treated failing heart. J Physiol Sci. 2019;69(2):295–303. PMID: 30414045. PMCID: PMC10717668. https://doi.org/10.1007/s12576-018-0646-0Li M, Zheng C, Kawada T, Inagaki M, Uemura K, Sugimachi M. Chronic vagal nerve stimulation exerts additional beneficial effects on the beta-blocker-treated failing heart. J Physiol Sci. 2019;69(2):295–303. PMID: 30414045. PMCID: PMC10717668. https://doi.org/10.1007/s12576-018-0646-0Schwartz PJ, De Ferrari GM, Sanzo A, et al. Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail. 2008;10(9):884–891. PMID: 18760668. https://doi.org/10.1016/j.ejheart.2008.07.016Schwartz PJ, De Ferrari GM, Sanzo A, et al. Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail. 2008;10(9):884–891. PMID: 18760668. https://doi.org/10.1016/j.ejheart.2008.07.016De Ferrari GM, Crijns HJ, Borggrefe M, et al; CardioFit Multicenter Trial Investigators. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J. 2011;32(7):847–855. PMID: 21030409. https://doi.org/10.1093/eurheartj/ehq391De Ferrari GM, Crijns HJ, Borggrefe M, et al; CardioFit Multicenter Trial Investigators. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J. 2011;32(7):847–855. PMID: 21030409. https://doi.org/10.1093/eurheartj/ehq391Zannad F, De Ferrari GM, Tuinenburg AE, et al. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J. 2015;36(7):425–433. PMID: 25176942. PMCID: PMC4328197. https://doi.org/10.1093/eurheartj/ehu345Zannad F, De Ferrari GM, Tuinenburg AE, et al. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J. 2015;36(7):425–433. PMID: 25176942. PMCID: PMC4328197. https://doi.org/10.1093/eurheartj/ehu345Premchand RK, Sharma K, Mittal S, et al. Extended follow-up of patients with heart failure receiving autonomic regulation therapy in the ANTHEM-HF study. J Card Fail. 2016;22(8):639–642. PMID: 26576716. https://doi.org/10.1016/j.cardfail.2015.11.002Premchand RK, Sharma K, Mittal S, et al. Extended follow-up of patients with heart failure receiving autonomic regulation therapy in the ANTHEM-HF study. J Card Fail. 2016;22(8):639–642. PMID: 26576716. https://doi.org/10.1016/j.cardfail.2015.11.002Gold MR, Van Veldhuisen DJ, Hauptman PJ, et al. Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J Am Coll Cardiol. 2016;68(2):149–158. PMID: 27058909. https://doi.org/10.1016/j.jacc.2016.03.525Gold MR, Van Veldhuisen DJ, Hauptman PJ, et al. Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J Am Coll Cardiol. 2016;68(2):149–158. PMID: 27058909. https://doi.org/10.1016/j.jacc.2016.03.525Anand IS, Konstam MA, Klein HU, et al. Comparison ofsymptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF. ESC Heart Fail. 2020;7(1):75–83. PMID: 31984682. PMCID: PMC7083506. https://doi.org/10.1002/ehf2.12592Anand IS, Konstam MA, Klein HU, et al. Comparison ofsymptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF. ESC Heart Fail. 2020;7(1):75–83. PMID: 31984682. PMCID: PMC7083506. https://doi.org/10.1002/ehf2.12592Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20(6):421–428. PMID: 10213345. https://doi.org/10.1053/euhj.1998.1280Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20(6):421–428. PMID: 10213345. https://doi.org/10.1053/euhj.1998.1280Гаврюшина С.В., Агеев Ф.Т. Сердечная недостаточность с сохраненной фракцией выброса левого желудочка: эпидемиология, «портрет» больного, клиника и диагностика. Кардиология. 2018;58(4S):55–64. https://doi.org/10.18087/cardio.2467Gavryushina SV, Ageev FT. Heart failure with preserved left ventricular ejection fraction: epidemiology, patient «portrait»,clinic and diagnostics. Kardiologiia. 2018;58(4S):55–64. (InRuss.). https://doi.org/10.18087/cardio.2467Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134(1):73–90. PMID: 27358439. PMCID: PMC4930115. https://doi.org/10.1161/CIRCULATIONAHA.116.021884.Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134(1):73–90. PMID: 27358439. PMCID: PMC4930115. https://doi.org/10.1161/CIRCULATIONAHA.116.021884.

The authors declare that there are no conflicts of interest present.